Editing CSL Limited (section)

{{Short description|Australian biotechnology company}}
{{About |Australian biotech company |other companies named CSL |CSL (disambiguation)}}
{{Use dmy dates|date=December 2022}}
{{Multiple issues|
{{third-party|date=February 2016}}
{{update|date=November 2020}}
}}
{{Infobox company
| name = CSL Limited
| logo = CSL Limited logo.svg
| type = [[Public company|Public]]
| traded_as = {{ubl|{{ASX|CSL}}|[[S&P/ASX 200]] component}}
| company_slogan = 
| foundation = 1916 (Federal government department), 1994 (privatised)
| hq_location = [[Parkville, Victoria|Parkville]], [[Melbourne]], [[Victoria (state)|Victoria]], [[Australia]] (Global),<ref name="AR19">{{cite web|url=https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf?la=en-us&hash=AC57DA1C6E85B66162B25238509C47596E1CA401|title=Annual Report 2019|publisher=CSL Limited|date=2019}}</ref>
| key_people = Paul McKenzie (CEO)
| industry = [[Biotechnology]]
| products = [[blood plasma]], [[vaccination|vaccines]], [[antivenom]], other laboratory and medical products
| revenue = {{currency|14.8 billion|passthrough=yes}} (2024)<ref name="AR2122"/>
| net_income = {{profit}} {{currency|2.91 billion|passthrough=yes}} (2024)<ref name="AR2122">{{cite web|url=https://investors.csl.com/annualreport/2022/4/|date=April 2022|access-date=29 March 2023|title=CSL Annual Report 2021/22|publisher=CSL Limited}}</ref>
| num_employees = 32,000 (2024)<ref name="AR2122"/>
| divisions = {{Unbulleted list|[[CSL Behring]]|[[CSL Plasma]]|[[CSL Seqirus]]|[[CSL Vifor]]}}
| homepage = {{URL|https://www.csl.com/}}
}}
'''CSL Limited''' is an Australian [[Multinational corporation|multinational]] specialty [[biotechnology]] company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include [[blood plasma]] derivatives, [[vaccination|vaccines]], [[antivenom]], and cell culture reagents used in various medical and genetic research and manufacturing applications.<ref>{{cite web |url= http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CSL:AU |archive-url= https://archive.today/20130118153023/http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CSL:AU |url-status= dead |archive-date= 18 January 2013 |title=CSL LTD (CSL:ASX): Stock Quote & Company Profile|work=Bloomberg Businessweek|access-date=13 August 2012}}</ref> The company was established in 1916 as '''Commonwealth Serum Laboratories''' and was wholly owned by the Australian federal government until its privatisation in 1994.